Cenra Inc. (TPE:3716)
Taiwan · Delayed Price · Currency is TWD 32.90
-0.25 (-0.75%)
At close: Nov 6, 2026
Cenra Market Cap
Cenra has a market cap or net worth of 4.79 billion as of November 6, 2026. It is the 22,359th most valuable company in the world and the 1,047th biggest in Taiwan. Its market cap has decreased by 3.03% in one year.
Market Cap
4.79B
Enterprise Value
6.88B
Revenue
8.44B
Global Rank
Country Rank
#1,047 Taiwan
PE Ratio
8.08
ChartMarket Cap Chart
Since September 2, 2024, Cenra's market cap has decreased from 6.21B to 4.79B, a decrease of -22.75%. That is a compound annual growth rate of -11.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 4.79B | -1.84% |
| Dec 31, 2025 | 4.88B | -12.15% |
| Dec 31, 2024 | 5.56B | -10.42% |
| Sep 2, 2024 | 6.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 526.33B |
| Lin BioScience | 121.06B |
| Caliway Biopharmaceuticals | 99.55B |
| Heron Neutron Medical | 63.59B |
| Formosa Optical Technology | 5.20B |
| Delta Asia International | 5.17B |
| Alar Pharmaceuticals | 4.93B |
| Yoda Pharmaceuticals | 4.74B |